These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure. Echouffo-Tcheugui JB; Masoudi FA; Bao H; Spatz ES; Fonarow GC Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27489243 [TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
7. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
9. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827 [TBL] [Abstract][Full Text] [Related]
10. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]
11. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259 [TBL] [Abstract][Full Text] [Related]
12. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy. Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940 [TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733 [TBL] [Abstract][Full Text] [Related]
14. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial. Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754 [TBL] [Abstract][Full Text] [Related]
15. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D; Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557 [TBL] [Abstract][Full Text] [Related]
16. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death]. Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820 [TBL] [Abstract][Full Text] [Related]
17. Cardiac resynchronization therapy improves psycho-cognitive performance in patients with heart failure. Duncker D; Friedel K; König T; Schreyer H; Lüsebrink U; Duncker M; Oswald H; Klein G; Gardiwal A Europace; 2015 Sep; 17(9):1415-21. PubMed ID: 25745071 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction. Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537 [TBL] [Abstract][Full Text] [Related]
19. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT. Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ; Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234 [TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator. Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]